Evidence map›Paper›PMID 27314915›Full record

ArticleCell adhesion & migration2017

Study of the involvement of allogeneic MSCs in bone formation using the model of transgenic mice.

Daria Kuznetsova, Natalia Prodanets, Svetlana Rodimova, Evgeny Antonov, Aleksandra Meleshina, Peter Timashev, Elena Zagaynova

Abstract read
In one paragraph

Article in Cell adhesion & migration, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daria Kuznetsovaa Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Natalia Prodanetsa Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Svetlana Rodimovab Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod , Nizhny Novgorod , Russia.
Evgeny Antonovc Institute of Laser and Information Technologies, Russian Academy of Sciences , Troitsk , Russia.
Aleksandra Meleshinaa Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Peter Timashevd Sechenov First Moscow State Medical University, Research Institute for Uronephrology and Reproductive Health , Moscow , Russia.
Elena Zagaynovaa Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are thought to be the most attractive type of cells for bone repair. However, much still remains unknown about MSCs and needs to be clarified before this treatment can be widely applied in the clinical practice. The purpose of this study was to establish the involvement of allogeneic MSCs in the bone formation in vivo, using a model of transgenic mice and genetically labeled cells. Polylactide scaffolds with hydroxyapatite obtained by surface selective laser sintering were used. The scaffolds were sterilized and individually seeded with MSCs from the bone marrow of 5-week-old GFP(+) transgenic C57/Bl6 or GFP(-)C57/Bl6 mice. 4-mm-diameter critical-size defects were created on the calvarial bone of mice using a dental bur. Immediately after the generation of the cranial bone defects, the scaffolds with or without seeded cells were implanted into the injury sites. The cranial bones were harvested at either 6 or 12 weeks after the implantation. GFP(+) transgenic mice having scaffolds with unlabeled MSCs were used for the observation of the host cell migration into the scaffold. GFP(-) mice having scaffolds with GFP(+)MSCs were used to assess the functioning of the seeded MSCs. The obtained data demonstrated that allogeneic MSCs were found on the scaffolds 6 and 12 weeks post-implantation. By week 12, a newly formed bone tissue from the seeded cells was observed, without an osteogenic pre-differentiation. The host cells did not appear, and the control scaffolds without seeded cells remained empty. Besides, a possibility of vessel formation from seeded MSCs was shown, without a preliminary cell cultivation under controlled conditions.

Indexed as

Mesenchymal Stem CellsAnimalsCell DifferentiationHumansMiceMice, TransgenicOsteogenesisTissue EngineeringTissue Scaffoldsbone formationfluorescence imagingGFPMesenchymal stem cellstransgenic mice

Identifiers

PMID27314915
PMCPMC5479449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.